Private Equity
Private Equity
All Portfolio items
See full Private Equity portfolio
With the acquisitions of Chr. Diener (2022), Koscher & Würtz (2023), Rudischhauser (2026), BENTEC Endoscopy (2026) and Hermann Medizintechnik (2026) Gilde Healthcare has formed the leading group of specialized contract manufacturers SPI Group (“SPI”). Building on market leading reputations and many decades of experience, the companies specialize in designing and manufacturing precision surgical instruments. SPI manufactures reusable- and disposable instruments and implants, for world-class Original Equipment Manufacturers in various fields of surgery, including orthopaedic- and spinal surgery, endoscopy and neurosurgery.
The group employes ca.500 highly skilled workers across six production locations in the south of Germany. Being part of one group allows the companies to offer their clients an even broader portfolio of products, while benefitting from the sharing of expertise and best practices.
With ongoing consolidation in the surgical instrument market, Gilde Healthcare sees opportunities to continue to expand the group through further acquisitions.
More SPI news
BENTEC Endoscopy joins Gilde Healthcare’s contract manufacturing group for surgical instruments and implants
Gilde Healthcare backed MedTech Group acquires precision surgical instruments and implants contract manufacturer Rudischhauser
Gilde Healthcare appoints Dr. Christian Stark as Group CEO of its globally operating medical technology group
Gilde Healthcare invests in German precision surgical instruments contract manufacturer Koscher & Würtz
Gilde Healthcare invests in German precision surgical instruments contract manufacturer Chr. Diener
Private Equity
NIZO
NIZO is a state-of-the art, globally operating contract research organization for better food and health outcomes with headquarters in Ede, the Netherlands. It focuses on the development and application of innovative technologies for its customers in the global food industry
Private Equity
Synexa Life Sciences
Synexa Life Sciences is a biomarker and bioanalytical lab CRO, specialising in the development, validation and delivery of a wide range of complex and custom-designed assays. With a team of over 200 staff across three global laboratory locations; Manchester, Turku
Private Equity
RAD-x
RAD-x is a leading European diagnostic imaging practice operating in Germany and Switzerland, it offer teleradiology services to support hospitals and diagnostic imaging groups. RAD-x grows by acquiring successful diagnostic imaging centers whose radiologists are looking for a solution for